Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra

NeuroReport

Volumn 10, Issue 3, 1999, Pages 557-561

  Parain, Karine ^a   Murer, M Gustavo ^b   Yan, Qiao ^c   Faucheux, Baptiste ^a   Agid, Yves ^a   Hirsch, Etienne ^a   Raisman Vozari, Rita ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c AMGEN INC   (United States)

Author keywords

BDNF; Lewy bodies; Neuromelanin; Parkinson's disease; Substantia nigra

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LEWY BODY; MALE; MESENCEPHALON; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

EID: 0033602009     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199902250-00021     Document Type: Article

References (25)

1. 1. Barde YA. Neuron 2, 1525-1534 (1989).
2. 2. Barbacid M. Curr Op Cell Biol 7, 148-155 (1995).
3. 3. Altar CA and DiStefano PS. Trends Neurosci 21, 433-437 (1998).
4. 4. Lindsay RM, Wiegand SJ, Altar CA et al. Trends Neurosci 17, 182-190 (1994).
5. 5. Hyman C, Hofer M, Barde Y-A et al. Nature 350, 230-232 (1991).
6. 6. Knüsel B, Winslow JW, Rosenthal A et al. Proc natl Acad Sci USA 88, 961-965 (1991).
7. 7. Beck KD, Knüsel B and Hefti F. Neuroscience 52, 855-866 (1993).
8. 8. Spina MB, Squinto SP, Miller J et al. J Neurochem 59, 99-106 (1992).
9. 9. Shults CW, Kimber T and Altar CA. NeuroReport 6, 1109-1112 (1995).
10. 10. Haag T. Exp Neurol 149, 183-192 (1998).
11. 11. Benitsy S, Boissiere F, Faucheux B et al. Neuroscience 86, 813-826 (1998).
12. 12. Murer MG, Boissière F, Yan Q et al. Neuroscience, in press.
13. 13. Yan Q, Rosenfeld RD, Matheson CR et al. Neuroscience 78, 431-448 (1997).
14. 14. Yan Q, Radeke MJ, Matheson CR et al. J Comp Neurol 378, 135-157 (1997).
15. 15. Zigmond MJ, Hastings TG and Abercrombie ED. Ann NY Acad Sci 648, 71-86 (1992).
16. 16. Altar CA, Boylan CB, Fritsche M et al. J Neurochem 63, 1021-1032 (19
17. 17. Kokaia Z, Gido G, Ringstedt T et al. Mol Brain Res 19, 277-286 (1993).
18. 18. Wong JY, Liberatore GT, Donnan GA et al. Exp Neurol 148, 83-91 (1997).
19. 19. Hirsch E, Graybiel AM and Agid Y. Nature 334, 345-348 (1988).
20. 20. Prigent A, Karlsson JO, Agid Y et al. Neuroscience 73, 979-987 (1996).
21. 21. Lang AE and Lozano AM. New Engl J Med 339, 1044-1053 (1998).
22. 22. Giehl KM, Schütte A, Mestres P et al. J Neurosci 18, 7351-7360 (1998).
23. 23. Numan S and Serogy KB. Eur J Neurosci 9, 489-495 (1997).
24. 24. Sauer H, Campbell K, Wiegand SJ et al. NeuroReport 5, 609-612 (1994).
25. 25. Okazawa H, Murata M, Watanabe M et al. FEBS Lett 313, 138-142 (1992).